Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: A case-control study

Lung Cancer

Volumn 40, Issue 1, 2003, Pages 25-32

  Wang, Yunfei ^a   Spitz, Margaret R ^a   Schabath, Matthew B ^a   Ali Osman, Francis ^a   Mata, Hilario ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Genetic susceptibility; Lung cancer; Molecular epidemiology; Single nucleotide polymorphism

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; GENE PRODUCT; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CATALYSIS; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME METABOLISM; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 0037379029     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00537-8     Document Type: Article

References (49)

1. Boyer T.D., Kenney W.C. Preparation, characterization and properties of glutathione S-transferases. Zakim D., Vessey D. Biochemical pharmacology and toxicology. 1985;297-363 Wiley, New York, NY.
2. Mannervik B. The isozymes of glutathione S-transferase. Adv. Enzymol. Relat. Areas Mol. Biol. 57:1985;357-417.
3. Pickett C.V., Lu A.Y. Glutathione S-transferases, gene structure, regulations, biological function. Annu. Rev. Biochem. 58:1989;743-764.
4. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
5. Strange R.C., Fryer A.A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci. Publ. 148:1999;231-249.
6. Terrier P., Townsend A.J., Coindre J.M., Triche T.J., Cowan K.H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 137:1990;845-853.
7. Anttila S., Hirvonen A., Vainio H., Husgafvel-Pursiainen K., Hayes J.D., Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung cancer. Cancer Res. 53:1993;5643-5648.
8. Saarikoski S.T., Voho A., Reinikainen M., Anttila S., Karjalainen A., Hirvonen A., et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer. 77:1998;516-521.
9. Zimniak P., Nandur B., Pikula S., Bandorowics-Pikula J., Singhal S., Awasthi Y., et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 105 differ in enzymatic properties. Eur. J. Biochem. 224:1994;893-899.
10. Waston M.A., Stewart R.K., Smith G.B.J., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275-280.
11. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 272:1997;10004-10012.
12. Maugard C.M., Charrier J., Pitard A., Campion L., Akande O., Ali-Osman F., et al. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int. J. Cancer. 91:2001;334-339.
13. Board P.G., Weber G.C., Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann. Hum. Genet. 53:1989;205-213.
14. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure - a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164.
15. Seidegard J., Pero R.W., Markowiz M.M., Roush G., Miller D.G., Beattie J. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer. Carcinogenesis. 11:1990;33-36.
16. Nazar-Stewart V., Motulsky A./G., Eaton D.L., White E., Hornung S.K., Weiss N.S., et al. The glutathione S-transferase μ polymorphism as a marker for the susceptibility to lung cancer. Cancer Res. 53:1993;2313-2318.
17. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 14:1993;1479-1481.
18. Chen H.W., Sandler D.P., Taylor A., Shore D.L., Liu E., Bell D.A., et al. Increased risk for myelodysplastic syndromes in individuals with glutathione-transferase theta 1 (GSTT1) gene defect. Lancet. 347:1996;295-297.
19. Vineis P, Malats N, Lang M, d'Errico, Caporaso N, Cuzick, Boffeta P. Metabolic Polymorphisms and Susceptibility to Cancer, International Agency for Research on Cancer, Lyon: IARC Scientific Publications No. 148; 1999.
20. Jourenkova-Mironova N., Wikman H., Bouchardy C., et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics. 8:1998;495-502.
21. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Haugen A., et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
22. Kihara M., Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Nippon Koshu Eisei Zasshi. 46:1999;241-249.
23. Jourenkova-Mironova N., Wikman H., Bouchardy C., Voho A., Dayer P., Hirvonen A., et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics. 8:1998;495-502.
24. To-Figueras J., Gene M., Gomez-Catalan J., Pique E., Borrego N., Corbella J., et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control. 10:1999;65-70.
25. Harris M.J., Coggan M., Langton L., Wilson S.R., Board P.G. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 8:1998;27-31.
26. Ozawa S., McDaniel L.P., Tang Y.M., Schoket B., Vincze I., Kadlubar F.F. CYP2C9 and GSTP1 genetic polymorphisms in patients with smoking-related lung cancer. Proc. Am. Assoc. Cancer Res. 38:1997;212.
27. Hudmon K.S., Honn S.E., Jiang H., et al. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidem. Biomark. Prev. 6:1997;565-571.
28. Harries L.W., Stubbins M.J., Forman D., Howard G.C.W., Wolf R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
29. McWilliams J.E., Evans A.J., Beer T.M., Andersen P.E., Cohen J.I., Henner W.D., et al. Genetic polymorphisms in head and neck cancer risk. Head Neck. 22:2000;609-617.
30. Helzlsouer K.J., Selmin O., Huang H.Y., Strickland P.T., Hoffman S., Bell D., et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90:1998;512-518.
31. Welfare M., Adeokun A.M., Bassendine M.F., Daly A.K. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidem. Biomark. Prev. 8:1999;289-292.
32. Curran J.E., Weinstein S.R., Griffiths L.R. Polymorphsms of glutathione S-transferase (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett. 2000;113-120.
33. Olshan A.F., Weissler M.C., Waston M.A., Bell D.A. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidem. Biomark. Prev. 9:2000;185-191.
34. Steinhoff C., Franke K.H., Golka K., Thier R., Romer H.C., Schulz W.A., et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch. Toxicol. 74:2000;521-526.
35. Spurdle A.B., Webb P.M., Purdie D.M., Chen X., Green A., Chenevix-Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis. 22:2001;67-72.
36. Gsur A., Haidinger G., Hinteregger S., Bernhofer G., Schatzl G., Micksche M., et al. Polymorphisms of glutathione S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate cancer risk. Int. J. Cancer. 95:2001;152-155.
37. Sata K. Glutathione transferases as markers of preneoplasia and neoplasia. Adv. Cancer Res. 52:1989;205-255.
38. Ranganathan S., Tew K.D. Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon. Carcinogenesis. 12:1991;2383-2387.
39. Shiratori Y., Soma Y., Maruyama H., Sato S., Takano A., Sato K. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Res. 5:1987;6806-6809.
40. Ali-Osman F., Brunner J.M., Kutluk T.M., Hess K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin. Cancer Res. 12:1997;2253-2261.
41. Gilbert L., Elwood L.J., Merino M., Masood S., Barnes R., Steinberg S.M., et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J. Clin. Oncol. 1:1993;49-58.
42. Duell E.J., Wiencke J.K., Cheng T.J., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 21:2000;965-971.
43. Yamada A., Yamada M., Fujita Y., Nishigami T., Nakasho K., Uematsu K. Self-augmentation effect of male-specific products on sexually differentiated progesterone metabolism in adult male rat liver microsomes. J. Biol. Chem. 276:2001;4604-4610.
44. Yuan B.B., Tchao R., Voigt J.M., Colby H.D. Maturational changes in CYP2D16 expression and xenobiotic metabolism in adrenal glands from male and female guinea pigs. Drug Metab. Dispos. 29:2001;194-199.
45. Hay Kraus B.L., Greenblatt D.J., Venkatakrishnan K., Court M.H. Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences. Xenobiotica. 30:2000;575-588.
46. Helzlsouer K.J., Alberg A.J., Huang H.Y., Hoffman S.C., Strickland P.T., Comstock G.W. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidem. Biomark. Prev. 8:1999;525-532.
47. Gudmundsdottir K., Tryggvadottir L., Eyfjord J.E. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidem. Biomark. Prev. 10:2001;1169-1173.
48. Dialyna I.A., Arvanitis D.A., Spandidos D.A. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. Int. J. Mol. Med. 8:2001;79-87.
49. Millikan R., Pittman G., Tse C.K., Savitz D.A., Newman B., Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidem. Biomark. Prev. 9:2000;567-573.